当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
Altreno lotion
儿科标签批准日期
2018/8/23 0:00:00
特定指示/秒
Topical treatment of acne vulgaris
标签更改摘要
- Safety and effectiveness have been established in pediatric patients age 9 years to less than 17 years based on evidence from two multicenter, randomized, double-blind, 12-week trials and an open-label pharmacokinetic study. A total of 318 pediatric subjects aged 9 to less than 17 years received Altreno in the clinical studies.
- Safety and effectiveness in pediatric patients below the age of 9 years have not been established.
- Information clinical trials, PK parameters, and adverse reactions
- New dosage form.
研究年龄
9 YEARS - 16 YEARS
9 YEARS - 17 YEARS
9 YEARS - 17 YEARS
学习类型
Safety,Pharmacokinetic
Efficacy,Safety
Efficacy,Safety
研究设计
Open-Label,Trad PK
Single-Blind,Parallel Group
Single-Blind,Parallel Group
西班牙裔拉美裔/拉丁裔总计
N/A
N/A
N/A
非西班牙裔/非拉丁裔总人数
N/A
N/A
N/A
美洲印第安人/阿拉斯加本地人总数
N/A
N/A
N/A